Abstract
Urothelial cancer (UC) of the bladder is a relatively common disease seen in Americans, especially those who have significant tobacco exposure history. While the signs and symptoms of UC can be straight-forward (e.g., hematuria, irritative voiding symptoms), a complete work-up is required to appropriately stage each patient. The work-up of UC consists of: a high level of suspicion for patients with hematuria to prevent missed or delayed diagnoses; an exam under anesthesia; imaging studies; urinary markers and cytology; cystoscopy and transurethral resection of the bladder tumor (TURBT), as well as potential repeat TURBT to prevent understaging and residual disease.
Keywords: Urothelial cancer, bladder cancer, TURBT, diagnosis
Current Cancer Therapy Reviews
Title: The Optimal Diagnosis of Urothelial Carcinoma of the Bladder
Volume: 7 Issue: 4
Author(s): Alan M. Nieder, Jeetu Nebhnani and Fernando J. Bianco
Affiliation:
Keywords: Urothelial cancer, bladder cancer, TURBT, diagnosis
Abstract: Urothelial cancer (UC) of the bladder is a relatively common disease seen in Americans, especially those who have significant tobacco exposure history. While the signs and symptoms of UC can be straight-forward (e.g., hematuria, irritative voiding symptoms), a complete work-up is required to appropriately stage each patient. The work-up of UC consists of: a high level of suspicion for patients with hematuria to prevent missed or delayed diagnoses; an exam under anesthesia; imaging studies; urinary markers and cytology; cystoscopy and transurethral resection of the bladder tumor (TURBT), as well as potential repeat TURBT to prevent understaging and residual disease.
Export Options
About this article
Cite this article as:
M. Nieder Alan, Nebhnani Jeetu and J. Bianco Fernando, The Optimal Diagnosis of Urothelial Carcinoma of the Bladder, Current Cancer Therapy Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339411797642641
DOI https://dx.doi.org/10.2174/157339411797642641 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics
The thematic issue will focus on key areas such as lipid nanoparticles, mRNA therapeutics, drug delivery systems, nanotechnology in medicine, targeted therapy, non-viral vectors, precision medicine, and biomedical engineering.read more
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?
Current Pharmacogenomics Biocatalysis in the Pharmaceutical Industry. A Greener Future
Current Green Chemistry Antigene and Antiproliferative Effects of Triplex-Forming Oligonucleotide (TFO) Targeted on hmgb1 Gene in Human Hepatoma Cells
Anti-Cancer Agents in Medicinal Chemistry It is All About Proteases: From Drug Delivery to In Vivo Imaging and Photomedicine
Current Medicinal Chemistry Current State of the Art of New Tubulin Inhibitors in the Clinic
Current Clinical Pharmacology Potential Anti-cancer Drugs Commonly Used for Other Indications
Current Cancer Drug Targets Progresses in TCM Metal-Based Antitumour Agents
Anti-Cancer Agents in Medicinal Chemistry Targeted Alpha Therapy with 213Bi
Current Radiopharmaceuticals Zebrafish Model in Drug Safety Assessment
Current Pharmaceutical Design Chlorine, Chlorination By-Products and Their Allergic and Respiratory Health Effects
Current Respiratory Medicine Reviews Oxygen Sensing, Cardiac Ischemia, HIF-1α and Some Emerging Concepts
Current Cardiology Reviews Sentinel Node Imaging
Current Medical Imaging Vasoactive Intestinal Peptide Receptors: A Molecular Target in Breast and Lung Cancer
Current Pharmaceutical Design Prebiotic Carbohydrates for Therapeutics
Endocrine, Metabolic & Immune Disorders - Drug Targets Trends in the Exploration of Anticancer Targets and Strategies in Enhancing the Efficacy of Drug Targeting
Current Molecular Pharmacology Radiosensitizing Effect of Electrochemotherapy: A Systematic Review of Protocols and Efficiency
Current Drug Targets Editorial [Human Methylome Variation and the Rise of Epigenetic Epidemiology]
Current Pharmacogenomics and Personalized Medicine The Production of Solid Dosage Forms from Non-Degradable Polymers
Current Pharmaceutical Design rDNA Mediated Bioconjugates: Fusion Proteins and their Intended Use in Medicine
Current Topics in Medicinal Chemistry Association of N-Acetyltransferase-2 Genotypes and Anti-Tuberculosis Induced Liver Injury: First Case-Controlled Study from Iran
Current Drug Safety